FDA Investigator David A Oluwo

David A Oluwo has inspections in 4 countries as of 03 Nov 2023. David A Oluwo has collaborated with a combinined 5198 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
52
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100005870
Country:
United States of America, Canada, Switzerland, Finland
Co-Investigator(s):
Abby E Pelletier, Adetutu M Gidado, Alberto A Viciedo, Alice S Tsao, Alison N Correll, Alison N Stieg, Amit Kokate, Amy N Chen, Anastasia I Offordile, Anastasia M Shields, Anita R Michael, Anitha P Govada, Ankur C Patel, Anna Lazar, Annemarie Bodnar, Anthony A Charity, Anthony F Lorenzo, Anthony J Ladner, Anthony W Hite, Audrey Thereset Uy, Azza Talaat, Azzu Talaat, Barbara A Gullick, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Bijoy Panicher, Bijoy Panicker, Brandi L Garbutt, Brian D Young, Brian R Yaun, Brittany L Carpenter, Brooke K Higgins, Brooke K Seeman, Bryan A Galvez, Bryan J Love, Burnell M Henry, Candice C Mandera, Candice J Cortes, Carrie L Doupnik, CDR Ileana Barreto Pettit, Chaltu N Wakijra, Charanjeet Jassal, Chiang Syin, PhD, Christian D Lynch (CDL), Christina K Theodorou, Christine M O'leary, Christopher D Leach, Colleen M Damon, Concepcion Cruz, Jr, Craig D Zagata, Cynthia A Harris, MD, RN, Cynthia A Palmer, Cynthia J Lee, MS, Cynthia White, Daniel J Deciero, Daniel J Grabicki, Daniel J Min, Daniel J Roberts, Daniel L Zheng, Daniel Min, Daniel W Johnson, David J Hafner, David L Chon, Deborah J Parris, Debra L Pagano, Dennis L Doupnik, Derek S Dealy, Devon Jenkins, Deyaa Shaheen, Douglas A Campbell, Douglas C Kovacs, Dr. Dominick Roselle, Dr. Gang Wang, PhD, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward D Mcdonald, Edwin L Hobbs, Emest F Bizjak, Emmanuel J Ramos, Eric L Dong, BS, Erik W Koester, Erk W Koester, Fred Razzaghi, Freddy Ortiz Colon, Frederick Razzaghi, Gayle S Lawson, George Pyramides, Gerald B Seaborn, Jr, Ginger M Sykes, Gwyn G Dickinson, H Ljamilla Selby, Hala L Selby, Hector J Colon Torres, Helen Verdel, Himanshu Gupta, PhD, Jacqueline Mdiaz Albertini, Jai P Singh, Jaison J Eapen, James M Mason, James M Simpson, James P Mcevoy, James R Birkenstamm, Janet A Rajan, Jay B Shah, Jay T Wong, Jeanne Fringer, PhD, Jeen S Min, Jeffery A Hangartner, Jessica L Pressley, Joel D Hustedt, Joey C West, Jogy George, Jonah S Ufferfilge, Jonah Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose R Hernandez, Joseph T Dougherty, Joseph W Matthews, Joshua P Wireman, Joy Rkozlowski Klena, Juanita P Versace, Julianne C Mccullough, Junho Pak, Justin A Boyd, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Karishma G Gopaul, Karyn M Campbell, Katherine D Adams, Kathleen M Jordan, Kelly N Kerr, Kendra L Brooks, Kenneth Gordon, Kenneth H Williams, Kenneth M Gordon, Kenneth Nieves, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Ko U Min, Kristen D Evans, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, Krystyna M Kitson, Kyle S Hobson, Lata C Mathew, PhD, Lauren L Vajo, Lauren N Barber, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Debra Emerson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, LCDR Wilfred A Darang, Li Lu, PhD, Linda K Cline, Linda M Hoover, Lisa B Orr, Lisa Shin, Logan T Williams, Loretta Nemchik, Lori M Newman, Lori S Lawless, LTJG Bradley E Benasutti, Luis A Dasta, Lydia Irosas Marty, Marc S Neubauer, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcus A Ray, Marea K Harmon, Margaret Faulkner, Margaret M Doherty, Margaret M Sands, Maria A Reed, Maria Estrella, Matthew M Henciak, Matthew R Mcnew, Matthew R Nooman, Matthew R Noonan, Maureen A Wentzel, Melissa J Garcia, Melissa T Roy, Meyer J Slobotsky, Michael A Charles, Michael Gurbarg, Michael L Casner, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Michele Gottshall, Mihaly S Ligmond, Mindy M Chou, Monique Rac Lester, Nadeem I Chaudhry, Namita Kothary, Nancy A Saxenian, Nancy A Saxenian Emmons, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nancy Sheraga, Natasha Gupta, Nathan B Davis, Nawab A Siddiqui, Nebil A Oumer, Nicholas A Violand, Nicholas L Paulin, Niketa Patel, Nikisha M Bolden, Odera I Ekwunife, Parul Patel Sullivan, Paul L Bellamy, Pushpa S Jayasekara, Qin Xu, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Rafeeq A Habeeb, Raffi B Papazian, Rebecca Rodriguez, Robert B Shibuya, MD, Robert H Wittorf, Robert J Maffei, Robert J Martin, Robin Levis, PhD, Rochelle L Cross, Rosario D'costa, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Sam Pepe, Samina S Khan, Sandra A Boyd, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shirley S Wen, Shirshendu K Deb, PhD, Simone E Pitts, Srinivas R Chennamaneni, PhD, State Agency, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen D Eich, Steven E Kane, Steven J Thurber, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Suzanne M Healy, Swati Verma, Tajah L Blackburn, Tamil Arasu, PhD, Tammy L Chavis, Tammy M Phillips, Tanya R Syffrard, Tekalign Wondimu, Temar Q Williams, Terri L Dodds, Thai D Truong, Thomas E Friel, Thomas J Arista, Thomas R Withers, Tiffani D Wilson, Timothy T Kapsala, Tonia F Bernard, Toyin B Oladimeji, Unnee Ranjan, Veronica Fuentes, MS, Viviana Matta, Vivin George, Vlada Matusovsky, Walden H Lee, Walter L Fava, Wanda Y Honeyblue, William H Linkroum, Yong Wu, PhD, Young M Yoon, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zachary A Bogorad, Zhong Li, PhD, Zhongren Wu

David A Oluwo's Documents

Publish Date Document Type Title
March, 2020 FDA 483 Exel Inc. - Form 483, 2020-03-13
June, 2019 FDA 483 AG Essence Inc - Form 483, 2019-06-11
November, 2017 EIR Accupac, LLC - EIR, 2017-11-02
July, 2018 FDA 483 Digestive Care, Inc. - Form 483, 2018-07-27
November, 2018 EIR Pharmaceutics International, Inc. - EIR, 2018-11-09
May, 2021 FDA 483 Dercher Enterprises, Inc., DBA Gordon Laboratories - Form 483, 2021-05-04
November, 2017 FDA 483 Accupac, LLC - Form 483, 2017-11-02
February, 2019 FDA 483 High Chemical Company, Div of National Generic Distributors - Form 483, 2019-02-08
August, 2022 FDA 483 APPCO PHARMA LLC - Form 483, 2022-08-19
January, 2023 FDA 483 Novel Laboratories, Inc. - Form 483, 2023-01-13
May, 2019 FDA 483 JBC Corp - Form 483, 2019-05-24
September, 2021 FDA 483 W.S. BADGER COMPANY, INC. - Form 483, 2021-09-14
August, 2023 FDA 483 MacroGenics, Inc - Form 483, 2023-08-28
July, 2016 FDA 483 Response STI Pharma LLC - Form 483R, 2016-08-08
April, 2023 FDA 483 Similasan AG - Form 483, 2023-04-04
January, 2020 FDA 483 Abbey Color Incorporated - Form 483, 2020-01-29
July, 2021 FDA 483 ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2021-07-01
May, 2022 FDA 483 Ferring Production Inc. - Form 483, 2022-05-12
January, 2017 FDA 483 Dercher Enterprises, Inc., DBA Gordon Laboratories - Form 483, 2017-01-19
December, 2019 FDA 483 WES PHARMA INC - Form 483, 2019-12-20
January, 2020 EIR Abbey Color Incorporated - EIR, 2020-01-29
November, 2018 FDA 483 Pharmaceutics International, Inc. - Form 483, 2018-11-09
December, 2021 FDA 483 Aurolife Pharma LLC - Form 483, 2021-12-07
July, 2018 FDA 483 Izeen Pharma Inc - Form 483, 2018-07-03
January, 2020 FDA 483 Vilvet Pharmaceuticals Inc. - Form 483, 2020-01-10
February, 2022 FDA 483 I 3 PHARMACEUTICALS, LLC - Form 483, 2022-02-22
November, 2018 EIR Pharmaceutics International, Inc. - EIR, 2018-11-09
September, 2019 FDA 483 Genus Lifesciences Inc. - Form 483, 2019-09-20
July, 2019 FDA 483 Keystone Rx LLC - Form 483, 2019-07-12
June, 2019 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2019-06-28
July, 2016 FDA 483 STI Pharma LLC - Form 483, 2016-07-21
July, 2023 FDA 483 Airgas Usa, LLC - Form 483, 2023-07-27
December, 2023 FDA 483 C.B. Fleet Company, Inc. - Form 483, 2023-12-01
January, 2024 FDA 483 Cardinal Health 414, LLC - Form 483, 2024-01-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more